Study Complete
Sponsor ID
20020134
Pegfilgrastim Administered on the Same Day as Chemotherapy in Non-Hodgkin’s Lymphoma
Study Details
The purpose of this study is to provide data on the safety and efficacy of pegfilgrastim when administered on the same day versus the next day of chemotherapy, as measured by the duration of grade 4 neutropenia.
Protocol Summary
Primary Outcome Measures
Reduce the duration of neutropenia and incidence of febrile neutropenia.
Timeframe: The primary outcome will be evaluated at the end of the study.
Secondary Outcome Measures
On the same day as chemotherapy as measured by the incidence of hematologic and non-hematologic toxicities, the number of subjects who received planned doses of chemotherapy on time and response rates.
Timeframe: The secondary outcome will be evaluated at the end of the study.
Locations
No locations found.